Advanced breast cancer incidence following population-based mammographic screening

P Autier, M Boniol, R Middleton, J F Doré, C Héry, T Zheng, A Gavin

Research output: Contribution to journalLiterature review

90 Citations (Scopus)

Abstract

Breast cancer mortality is declining in many Western countries. If mammography screening contributed to decreases in mortality, then decreases in advanced breast cancer incidence should also be noticeable.
We assessed incidence trends of advanced breast cancer in areas where mammography screening is practiced for at least 7 years with 60% minimum participation and where population-based registration of advanced breast cancer existed. Through a systematic Medline search, we identified relevant published data for Australia, Italy, Norway, Switzerland, The Netherlands, UK and the USA. Data from cancer registries in Northern Ireland, Scotland, the USA (Surveillance, Epidemiology and End Results (SEER), and Connecticut), and Tasmania (Australia) were available for the study. Criterion for advanced cancer was the tumour size, and if not available, spread to regional/distant sites.
Age-adjusted annual percent changes (APCs) were stable or increasing in ten areas (APCs of −0.5% to 1.7%). In four areas (Firenze, the Netherlands, SEER and Connecticut) there were transient downward trends followed by increases back to pre-screening rates.
In areas with widespread sustained mammographic screening, trends in advanced breast cancer incidence do not support a substantial role for screening in the decrease in mortality.
LanguageEnglish
Pages1726-1735
Number of pages10
JournalAnnals of Oncology
Volume22
Issue number8
Early online date20 Jan 2011
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Breast Neoplasms
Incidence
Population
Mammography
Netherlands
Mortality
Epidemiology
Tasmania
Northern Ireland
Neoplasms
Scotland
Norway
Switzerland
Italy
Registries

Keywords

  • mammography
  • neoplasm staging
  • screening
  • cancer registry
  • early detection of cancer
  • breast neoplasms
  • middle aged females

Cite this

Autier, P., Boniol, M., Middleton, R., Doré, J. F., Héry, C., Zheng, T., & Gavin, A. (2011). Advanced breast cancer incidence following population-based mammographic screening. Annals of Oncology, 22(8), 1726-1735. https://doi.org/10.1093/annonc/mdq633
Autier, P ; Boniol, M ; Middleton, R ; Doré, J F ; Héry, C ; Zheng, T ; Gavin, A. / Advanced breast cancer incidence following population-based mammographic screening. In: Annals of Oncology. 2011 ; Vol. 22, No. 8. pp. 1726-1735.
@article{ef091b2d68f84d95a718e5f2c8c2c578,
title = "Advanced breast cancer incidence following population-based mammographic screening",
abstract = "Breast cancer mortality is declining in many Western countries. If mammography screening contributed to decreases in mortality, then decreases in advanced breast cancer incidence should also be noticeable.We assessed incidence trends of advanced breast cancer in areas where mammography screening is practiced for at least 7 years with 60{\%} minimum participation and where population-based registration of advanced breast cancer existed. Through a systematic Medline search, we identified relevant published data for Australia, Italy, Norway, Switzerland, The Netherlands, UK and the USA. Data from cancer registries in Northern Ireland, Scotland, the USA (Surveillance, Epidemiology and End Results (SEER), and Connecticut), and Tasmania (Australia) were available for the study. Criterion for advanced cancer was the tumour size, and if not available, spread to regional/distant sites.Age-adjusted annual percent changes (APCs) were stable or increasing in ten areas (APCs of −0.5{\%} to 1.7{\%}). In four areas (Firenze, the Netherlands, SEER and Connecticut) there were transient downward trends followed by increases back to pre-screening rates.In areas with widespread sustained mammographic screening, trends in advanced breast cancer incidence do not support a substantial role for screening in the decrease in mortality.",
keywords = "mammography, neoplasm staging, screening , cancer registry , early detection of cancer, breast neoplasms, middle aged females",
author = "P Autier and M Boniol and R Middleton and Dor{\'e}, {J F} and C H{\'e}ry and T Zheng and A Gavin",
year = "2011",
month = "8",
doi = "10.1093/annonc/mdq633",
language = "English",
volume = "22",
pages = "1726--1735",
journal = "Annals of Oncology",
issn = "1569-8041",
number = "8",

}

Autier, P, Boniol, M, Middleton, R, Doré, JF, Héry, C, Zheng, T & Gavin, A 2011, 'Advanced breast cancer incidence following population-based mammographic screening' Annals of Oncology, vol. 22, no. 8, pp. 1726-1735. https://doi.org/10.1093/annonc/mdq633

Advanced breast cancer incidence following population-based mammographic screening. / Autier, P; Boniol, M; Middleton, R; Doré, J F; Héry, C; Zheng, T; Gavin, A.

In: Annals of Oncology, Vol. 22, No. 8, 08.2011, p. 1726-1735.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Advanced breast cancer incidence following population-based mammographic screening

AU - Autier, P

AU - Boniol, M

AU - Middleton, R

AU - Doré, J F

AU - Héry, C

AU - Zheng, T

AU - Gavin, A

PY - 2011/8

Y1 - 2011/8

N2 - Breast cancer mortality is declining in many Western countries. If mammography screening contributed to decreases in mortality, then decreases in advanced breast cancer incidence should also be noticeable.We assessed incidence trends of advanced breast cancer in areas where mammography screening is practiced for at least 7 years with 60% minimum participation and where population-based registration of advanced breast cancer existed. Through a systematic Medline search, we identified relevant published data for Australia, Italy, Norway, Switzerland, The Netherlands, UK and the USA. Data from cancer registries in Northern Ireland, Scotland, the USA (Surveillance, Epidemiology and End Results (SEER), and Connecticut), and Tasmania (Australia) were available for the study. Criterion for advanced cancer was the tumour size, and if not available, spread to regional/distant sites.Age-adjusted annual percent changes (APCs) were stable or increasing in ten areas (APCs of −0.5% to 1.7%). In four areas (Firenze, the Netherlands, SEER and Connecticut) there were transient downward trends followed by increases back to pre-screening rates.In areas with widespread sustained mammographic screening, trends in advanced breast cancer incidence do not support a substantial role for screening in the decrease in mortality.

AB - Breast cancer mortality is declining in many Western countries. If mammography screening contributed to decreases in mortality, then decreases in advanced breast cancer incidence should also be noticeable.We assessed incidence trends of advanced breast cancer in areas where mammography screening is practiced for at least 7 years with 60% minimum participation and where population-based registration of advanced breast cancer existed. Through a systematic Medline search, we identified relevant published data for Australia, Italy, Norway, Switzerland, The Netherlands, UK and the USA. Data from cancer registries in Northern Ireland, Scotland, the USA (Surveillance, Epidemiology and End Results (SEER), and Connecticut), and Tasmania (Australia) were available for the study. Criterion for advanced cancer was the tumour size, and if not available, spread to regional/distant sites.Age-adjusted annual percent changes (APCs) were stable or increasing in ten areas (APCs of −0.5% to 1.7%). In four areas (Firenze, the Netherlands, SEER and Connecticut) there were transient downward trends followed by increases back to pre-screening rates.In areas with widespread sustained mammographic screening, trends in advanced breast cancer incidence do not support a substantial role for screening in the decrease in mortality.

KW - mammography

KW - neoplasm staging

KW - screening

KW - cancer registry

KW - early detection of cancer

KW - breast neoplasms

KW - middle aged females

UR - http://annonc.oxfordjournals.org/

U2 - 10.1093/annonc/mdq633

DO - 10.1093/annonc/mdq633

M3 - Literature review

VL - 22

SP - 1726

EP - 1735

JO - Annals of Oncology

T2 - Annals of Oncology

JF - Annals of Oncology

SN - 1569-8041

IS - 8

ER -